Intuitive Surgical, Inc. (NASDAQ:ISRG) CEO Gary S. Guthart sold 17,975 shares of the stock in a transaction that occurred on Thursday, July 27th. The stock was sold at an average price of $937.27, for a total value of $16,847,428.25. Following the completion of the transaction, the chief executive officer now directly owns 101,798 shares in the company, valued at approximately $95,412,211.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Intuitive Surgical, Inc. (NASDAQ ISRG) traded up 0.439% during trading on Friday, hitting $935.938. The company had a trading volume of 177,122 shares. Intuitive Surgical, Inc. has a 52-week low of $610.71 and a 52-week high of $974.66. The firm’s 50 day moving average is $937.07 and its 200-day moving average is $813.16. The stock has a market capitalization of $34.77 billion, a price-to-earnings ratio of 44.829 and a beta of 0.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share for the quarter, beating analysts’ consensus estimates of $5.79 by $0.16. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. The firm had revenue of $756.20 million during the quarter, compared to analysts’ expectations of $724.51 million. During the same period in the previous year, the company earned $5.62 earnings per share. Intuitive Surgical’s quarterly revenue was up 12.8% compared to the same quarter last year. On average, equities analysts forecast that Intuitive Surgical, Inc. will post $23.86 earnings per share for the current year.

WARNING: “Intuitive Surgical, Inc. (ISRG) CEO Sells $16,847,428.25 in Stock” was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2017/07/28/intuitive-surgical-inc-isrg-ceo-sells-16847428-25-in-stock.html.

Large investors have recently made changes to their positions in the stock. D. Scott Neal Inc. bought a new stake in shares of Intuitive Surgical during the second quarter worth $120,000. Guardian Life Insurance Co. of America boosted its stake in shares of Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock worth $109,000 after buying an additional 3 shares during the period. Acropolis Investment Management LLC bought a new stake in shares of Intuitive Surgical during the first quarter worth $115,000. Parallel Advisors LLC boosted its stake in shares of Intuitive Surgical by 10.1% in the first quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock worth $129,000 after buying an additional 14 shares during the period. Finally, Huntington National Bank boosted its stake in shares of Intuitive Surgical by 14.1% in the first quarter. Huntington National Bank now owns 170 shares of the medical equipment provider’s stock worth $130,000 after buying an additional 21 shares during the period. 97.56% of the stock is owned by hedge funds and other institutional investors.

Several brokerages recently issued reports on ISRG. Royal Bank Of Canada reissued a “hold” rating and issued a $1,000.00 price objective on shares of Intuitive Surgical in a research note on Friday, July 21st. Stifel Nicolaus increased their price objective on Intuitive Surgical from $800.00 to $850.00 and gave the stock a “buy” rating in a research note on Wednesday, April 19th. Canaccord Genuity reissued a “buy” rating and issued a $870.00 price objective (up previously from $800.00) on shares of Intuitive Surgical in a research note on Wednesday, April 19th. Goldman Sachs Group, Inc. (The) began coverage on Intuitive Surgical in a research note on Tuesday, May 16th. They issued a “buy” rating and a $1,000.00 price objective on the stock. Finally, Citigroup Inc. reissued a “buy” rating and issued a $1,078.00 price objective (up previously from $917.00) on shares of Intuitive Surgical in a research note on Monday. Six research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $980.03.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.